Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

175 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The use of adenoviral vectors for gene therapy and gene transfer in vivo.
Bramson JL, Graham FL, Gauldie J. Bramson JL, et al. Curr Opin Biotechnol. 1995 Oct;6(5):590-5. doi: 10.1016/0958-1669(95)80097-2. Curr Opin Biotechnol. 1995. PMID: 7579670 Review.
Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12.
Bramson J, Hitt M, Gallichan WS, Rosenthal KL, Gauldie J, Graham FL. Bramson J, et al. Hum Gene Ther. 1996 Feb 10;7(3):333-42. doi: 10.1089/hum.1996.7.3-333. Hum Gene Ther. 1996. PMID: 8835220
Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12.
Bramson JL, Hitt M, Addison CL, Muller WJ, Gauldie J, Graham FL. Bramson JL, et al. Hum Gene Ther. 1996 Oct 20;7(16):1995-2002. doi: 10.1089/hum.1996.7.16-1995. Hum Gene Ther. 1996. PMID: 8930660
Combination therapy with interleukin-2 and wild-type p53 expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancer.
Pützer BM, Bramson JL, Addison CL, Hitt M, Siegel PM, Muller WJ, Graham FL. Pützer BM, et al. Hum Gene Ther. 1998 Mar 20;9(5):707-18. doi: 10.1089/hum.1998.9.5-707. Hum Gene Ther. 1998. PMID: 9551618
Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors.
Addison CL, Bramson JL, Hitt MM, Muller WJ, Gauldie J, Graham FL. Addison CL, et al. Gene Ther. 1998 Oct;5(10):1400-9. doi: 10.1038/sj.gt.3300731. Gene Ther. 1998. PMID: 9930346
Adenoviral vectors: prospects for gene delivery to the central nervous system.
Parks RJ, Bramson JL. Parks RJ, et al. Gene Ther. 1999 Aug;6(8):1349-50. doi: 10.1038/sj.gt.3301013. Gene Ther. 1999. PMID: 10467358 No abstract available.
Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors.
Parks RJ, Bramson JL, Wan Y, Addison CL, Graham FL. Parks RJ, et al. J Virol. 1999 Oct;73(10):8027-34. doi: 10.1128/JVI.73.10.8027-8034.1999. J Virol. 1999. PMID: 10482551 Free PMC article.
J. Parks et al., Proc. Natl. Acad. Sci. USA 93:13565-13570, 1996). An hd vector deleted for approximately 70% of the Ad genome (AdRP1001) provided levels and durations of transgene expression similar to those of a control first generation Ad vector containing an identical
J. Parks et al., Proc. Natl. Acad. Sci. USA 93:13565-13570, 1996). An hd vector deleted for approximately 70% of the Ad genome (AdRP1
175 results
Jump to page
Feedback